MNCH Programming in Southwest Uganda Maternal and Child Health In Bushenyi and Rubirizi Districts, UGANDA

NCT01571765 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 10985

Last updated 2015-05-06

No results posted yet for this study

Summary

The investigators will assess whether in Bushenyi District in southwestern Uganda, a two year intervention providing comprehensive MNCH programming will:

* Reduce morbidity and mortality for children under five years old and;
* Improve access to maternal health services Compared to a control community without MNCH intervention?

Hypothesis:

Comprehensive maternal, newborn and child health programming in Bushenyi Distrcit can have a positive impact on morbidity and mortality for children under five years and will improve access for women to maternal health services which may lead, in the longer term, to decreased maternal mortality.

Conditions

  • Child Mortality
  • Maternal Mortality (All Cause)

Interventions

OTHER

MNCH programming in health district

training at health district level in management, data collection. Training at health centres in obstetrics and pediatrics and training in community of CHWs and bednet distribution

Sponsors & Collaborators

  • Canadian International Development Agency

    collaborator OTHER_GOV
  • University of Calgary

    lead OTHER

Principal Investigators

  • Jennifer Brenner, MD · University of Calgary

  • Jerome Kabakyenga, MBBS, PHD · Mbarara University of Science and Technology

Study Design

Allocation
NON_RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
15 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2012-04-30
Primary Completion
2014-07-31
Completion
2015-03-31

Countries

  • Uganda

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01571765 on ClinicalTrials.gov